Page last updated: 2024-08-24

aromasil and Age-Related Osteoporosis

aromasil has been researched along with Age-Related Osteoporosis in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (35.71)	29.6817
2010's	9 (64.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hattori, A; Hirano, A; Inoue, H; Kamimura, M; Kodera, A; Matsuoka, A; Naritaka, Y; Ogura, K; Sakaguchi, S; Shimizu, T; Tanaka, N; Yukawa, H	1
Bernhard, J; Bonnefoi, HR; Burstein, HJ; Ciruelos, E; Coates, AS; Colleoni, M; Crivellari, D; Fleming, GF; Francis, PA; Gelber, RD; Geyer, CE; Giobbie-Hurder, A; Goldhirsch, A; Gomez, HL; Láng, I; Luo, W; Maibach, R; Martino, S; Pagani, O; Perez, EA; Pinotti, G; Price, KN; Puglisi, F; Rabaglio-Poretti, M; Regan, MM; Ribi, K; Ruepp, B; Ruhstaller, T; Stearns, V; Tondini, C; Viale, G; Walley, BA; Winer, EP	1
Batzler, A; Carlson, EE; Chapman, JA; Ellis, MJ; Furukawa, Y; Goss, PE; Ingle, JN; Jenkins, GD; Khosla, S; Kubo, M; Liu, M; Nakamura, Y; Schaid, DJ; Shepherd, LE; Wang, L; Weinshilboum, RM	1
Charehbili, A; Fontein, DB; Kranenbarg, EM; Kroep, JR; Linn, SC; Nortier, JW; Putter, H; van de Velde, CJ	1
Giorgadze, E; Khachidze, N; Tsagareli, M	1
Gibson, K; O'Bryant, CL	1
Asmar, L; Blum, JL; Braun, M; Cantrell, J; Davis, JC; Di Salle, E; Ethirajan, S; Hartung, NL; Holmes, FA; Ilegbodu, D; Jones, S; Kutteh, L; Look, RM; Myron, MC; Patel, M; Paul, D; Pippen, J; Sborov, M; Stokoe, C	1
Tang, SC	1
Cauley, JA	1
Bordeleau, L; Cardew, S; Cheung, AM; Demaras, A; Elser, C; Erlandson, M; Goss, PE; Hu, H; Ingle, J; Kapral, MK; Khosla, S; Lickley, L; Majumdar, S; Pruthi, S; Richardson, H; Robbins, J; Scher, J; Tile, L; Tomlinson, G	1
Ansari, RH; Budd, GT; Chalchal, H; Chapman, JA; D'Souza, DP; Elliott, C; Ellis, MJ; Gelmon, KA; Goss, PE; Ingle, JN; Johnson, DB; Lang, I; Liedke, PE; Perez, EA; Pritchard, KI; Rabaglio, M; Shepherd, LE; Sledge, GW; Spadafora, S; Stearns, V; Tozer, R	1
Tanvetyanon, T	1
Aisaki, KI; Hatori, M; Igarashi, K; Kanno, J; Miki, Y; Nakamura, Y; Sasano, H; Sawai, T; Suzuki, T; Uzuki, M	1
Perez, EA	1

Reviews

3 review(s) available for aromasil and Age-Related Osteoporosis

Article	Year
ADJUVANT (HORMONAL) THERAPY AS A CAUSE OF BONE LOSS IN PATIENTS WITH BREAST CANCER (REVIEW OF LITERATURE). Georgian medical news, 2017, Issue:262 Topics: Anastrozole; Androstadienes; Aromatase Inhibitors; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Estrogen Antagonists; Female; Humans; Letrozole; Nitriles; Osteoporosis; Postmenopause; Premenopause; Selective Estrogen Receptor Modulators; Tamoxifen; Triazoles	2017
Women and bone health: maximizing the benefits of aromatase inhibitor therapy. Oncology, 2010, Volume: 79, Issue:1-2 Topics: Anastrozole; Androstadienes; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Breast Neoplasms; Colorectal Neoplasms; Denosumab; Diphosphonates; Female; Humans; Imidazoles; Letrozole; Nitriles; Osteoporosis; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; RANK Ligand; Secondary Prevention; Tamoxifen; Triazoles; Zoledronic Acid	2010
Safety of aromatase inhibitors in the adjuvant setting. Breast cancer research and treatment, 2007, Volume: 105 Suppl 1 Topics: Anastrozole; Androstadienes; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cardiovascular Diseases; Causality; Chemotherapy, Adjuvant; Comorbidity; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Incidence; Letrozole; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Neoplasms, Second Primary; Nitriles; Osteoporosis; Rats; Survival Analysis; Tamoxifen; Triazoles	2007

Trials

7 trial(s) available for aromasil and Age-Related Osteoporosis

Article	Year
Long-term effect of exemestane therapy on bone mineral density supported by bisphosphonates: Results of 5-year adjuvant treatment in postmenopausal women with early-stage breast cancer. Asia-Pacific journal of clinical oncology, 2018, Volume: 14, Issue:5 Topics: Aged; Androstadienes; Antineoplastic Agents; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Humans; Middle Aged; Osteoporosis; Postmenopause	2018
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. The New England journal of medicine, 2014, Jul-10, Volume: 371, Issue:2 Topics: Adult; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Estradiol; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Mastectomy; Middle Aged; Osteoporosis; Premenopause; Quality of Life; Tamoxifen; Triptorelin Pamoate	2014
Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics. Molecular endocrinology (Baltimore, Md.), 2014, Volume: 28, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Aromatase Inhibitors; Bone Density; Female; Gene-Environment Interaction; Genome-Wide Association Study; Genotype; Humans; Middle Aged; Nitriles; Osteoporosis; Osteoporotic Fractures; Polymorphism, Single Nucleotide; Triazoles	2014
Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04). European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2017, Volume: 43, Issue:4 Topics: Aged; Aged, 80 and over; Androstadienes; Aromatase Inhibitors; Arthralgia; Arthritis; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Disease-Free Survival; Female; Hot Flashes; Humans; Joint Diseases; Logistic Models; Magnetic Resonance Imaging; Mammography; Mastectomy; Middle Aged; Multivariate Analysis; Musculoskeletal Diseases; Myalgia; Neoadjuvant Therapy; Odds Ratio; Osteoporosis; Postmenopause; Prognosis; Receptors, Estrogen; Treatment Outcome; Ultrasonography, Mammary; Vasomotor System	2017
The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast cancer. Clinical breast cancer, 2008, Volume: 8, Issue:6 Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Female; Humans; Middle Aged; Osteoporosis; Postmenopause; Tamoxifen	2008
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial. The Lancet. Oncology, 2012, Volume: 13, Issue:3 Topics: Absorptiometry, Photon; Androstadienes; Anticarcinogenic Agents; Aromatase Inhibitors; Bone and Bones; Bone Density; Breast Neoplasms; Calcium; Canada; Chi-Square Distribution; Dietary Supplements; Double-Blind Method; Female; Femur Neck; Hip Joint; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis; Patient Selection; Placebos; Postmenopause; Primary Prevention; Risk Assessment; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; United States; Vitamin D	2012
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Apr-10, Volume: 31, Issue:11 Topics: Aged; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Female; Follow-Up Studies; History, 18th Century; Hot Flashes; Humans; Hypercholesterolemia; Kaplan-Meier Estimate; Middle Aged; Nitriles; Osteoporosis; Postmenopause; Time Factors; Treatment Outcome; Triazoles	2013

Other Studies

4 other study(ies) available for aromasil and Age-Related Osteoporosis

Article	Year
Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2008, Volume: 14, Issue:3 Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Bone Density Conservation Agents; Bone Diseases, Metabolic; Breast Neoplasms; Female; Humans; Letrozole; Middle Aged; Nitriles; Osteoporosis; Retrospective Studies; Triazoles	2008
Bone loss associated with prevention of breast cancer. The Lancet. Oncology, 2012, Volume: 13, Issue:3 Topics: Androstadienes; Anticarcinogenic Agents; Aromatase Inhibitors; Bone and Bones; Bone Density; Breast Neoplasms; Female; Humans; Osteoporosis; Postmenopause; Primary Prevention	2012
Adjuvant treatment of breast cancer with exemestane. The New England journal of medicine, 2004, Jul-01, Volume: 351, Issue:1 Topics: Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Resorption; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fractures, Bone; Humans; Osteoporosis; Tamoxifen	2004
Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: a possible androgenic bone protective effects induced by exemestane. Bone, 2007, Volume: 40, Issue:4 Topics: Alkaline Phosphatase; Aminoglutethimide; Androstadienes; Aromatase Inhibitors; Base Sequence; Cell Line; Cell Proliferation; DNA Primers; Estradiol; Flutamide; Gene Expression; Humans; Oligonucleotide Array Sequence Analysis; Osteoblasts; Osteoclasts; Osteoporosis; Receptors, Androgen; RNA, Messenger; Testosterone; Testosterone Congeners	2007